News Results
There are 371,571 News Results
Feb 8, 2018
NEW YORK, Feb. 9, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on OC, SUM, USG, and VMC...
Feb 8, 2018
SAN DIEGO, Feb. 9, 2018 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) today announced that Qualcomm River Holdings B.V., an indirect wholly owned subsidiary of Qualcomm, has extended the offering period...
Feb 8, 2018
ALBANY, New York, February 9, 2018 /PRNewswire/ -- The global bovine blood plasma market is currently gaining strong traction from the increasing demand for nutritious products in the food industry...
Feb 8, 2018
MARLBOROUGH, Mass., Feb. 9, 2018 /PRNewswire/ -- Lemelson Capital Management, LLC, a private investment management firm, announced today it is calling on the board of directors of the company to...
Feb 8, 2018
PUNE, India, February 9, 2018 /PRNewswire/ -- According to the new research report "Aircraft Fire Protection Systems Market by Product (Fire Detection System, Alarm & Warning, Fire Suppression), Application (Engine, Cabin &...
Feb 10, 2018
LONDON, February 12, 2018 /PRNewswire/ -- 7 Percent of UK Studios Employ 69 Per cent of Developers TIGA, the network for game developers and digital publishers, today released new findings...
Feb 12, 2018
SAN FRANCISCO, February 13, 2018 /PRNewswire/ -- The global advanced driver assistance system (ADAS) market [ https://www.grandviewresearch.com/industry-analysis/advanced-driver-assi... ] is expected to reach USD 67.43 billion by 2025, growing at a CAGR...
Feb 12, 2018
NEW YORK, Feb. 13, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on PTLA, PLX, RDUS, and RGLS...
Feb 12, 2018
SAN DIEGO, Feb. 13, 2018 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced that a planned...
Feb 12, 2018
RICHMOND, Calif., Feb. 13, 2018 /PRNewswire/ -- Sangamo Therapeutics (Nasdaq: SGMO) yesterday presented preclinical data demonstrating the Company's engineering capabilities in T cell genome editing using zinc finger nucleases (ZFNs)....
